SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-000136
Filing Date
2019-01-07
Accepted
2019-01-07 10:12:25
Documents
22
Period of Report
2019-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k00650118xa9c08.htm 8-K 26743
2 EXHIBIT 99.1 irpresentation1718.htm EX-99.1 22526
3 irpresentation1718001.jpg GRAPHIC 139958
4 irpresentation1718002.jpg GRAPHIC 195459
5 irpresentation1718003.jpg GRAPHIC 121834
6 irpresentation1718004.jpg GRAPHIC 136728
7 irpresentation1718005.jpg GRAPHIC 86972
8 irpresentation1718006.jpg GRAPHIC 127104
9 irpresentation1718007.jpg GRAPHIC 138269
10 irpresentation1718008.jpg GRAPHIC 122149
11 irpresentation1718009.jpg GRAPHIC 141621
12 irpresentation1718010.jpg GRAPHIC 140702
13 irpresentation1718011.jpg GRAPHIC 160769
14 irpresentation1718012.jpg GRAPHIC 107508
15 irpresentation1718013.jpg GRAPHIC 191381
16 irpresentation1718014.jpg GRAPHIC 108171
17 irpresentation1718015.jpg GRAPHIC 97592
18 irpresentation1718016.jpg GRAPHIC 121715
19 irpresentation1718017.jpg GRAPHIC 67156
20 irpresentation1718018.jpg GRAPHIC 119101
21 irpresentation1718019.jpg GRAPHIC 129469
22 irpresentation1718020.jpg GRAPHIC 67357
  Complete submission text file 0001628280-19-000136.txt   3525133
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 19512504
SIC: 2836 Biological Products, (No Diagnostic Substances)